This week, Caroline Hyde sat down with Allergan Chief Executive Brent Saunders for a wide-ranging interview as part of our CEO Spotlight Series. Saunders discussed high drug prices, selling Allergan to rival AbbVie for $63 billion, why his best career decision was taking a "huge" pay cut and what's coming next for him after the AbbVie deal.

See omnystudio.com/listener for privacy information.